NovoCure Limited (NVCR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 12.06 |
| Open | 12.09 |
| Bid | 12.32 x 200 |
| Ask | 12.41 x 300 |
| Day's Range | 12.02 - 12.39 |
| 52 Week Range | 10.87 - 83.60 |
| Volume | |
| Avg. Volume | 1,286,193 |
| Market Cap | 1.328B |
| Beta (5Y Monthly) | 0.43 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
NovoCure (NVCR) Moves to Buy: Rationale Behind the Upgrade
NovoCure (NVCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Zacks
NovoCure (NVCR) Soars 12.0%: Is Further Upside Left in the Stock?
NovoCure (NVCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- Investor's Business Daily
Novocure Surges 12% On Brain Tumors Study; But Some Analysts Are Bearish
Novocure stock surged Wednesday after its medtech device nearly doubled the length of time patients with brain tumors lived before worsening.
© 2024 Yahoo. All rights reserved.